Exchange: NASDAQ·Updated 07:41 PM EDT
ERAS logo

ERAS Erasca Inc

$18.10
$1.46
(7.49%)
Today
Closed $18.03
$0.07
(0.39%)
After Hours
Reported EarningsAug 11
Mkt Cap$6.31B
Vol2.89M

About ERAS

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
67

Bullish Sentiment

How do you feel about ERAS?

Advertisement|Remove ads.